相似文献
1
The Safety of PsA-TT in Pregnancy: An Assessment Performed Within the Navrongo Health and Demographic Surveillance Site in Ghana.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S489-92. doi: 10.1093/cid/civ625.
2
Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S493-500. doi: 10.1093/cid/civ497.
3
A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S507-13. doi: 10.1093/cid/civ626.
4
Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine.
Hum Vaccin Immunother. 2014;10(1):138-9. doi: 10.4161/hv.26347. Epub 2013 Sep 6.
5
Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
Vaccine. 2015 Mar 17;33(12):1492-8. doi: 10.1016/j.vaccine.2015.01.043. Epub 2015 Jan 28.
6
Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.
Vaccine. 2018 Jun 27;36(28):4102-4111. doi: 10.1016/j.vaccine.2018.05.046. Epub 2018 May 18.
7
Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
Lancet. 2014 Jan 4;383(9911):40-47. doi: 10.1016/S0140-6736(13)61612-8. Epub 2013 Sep 12.
8
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Lancet. 2000 Jan 1;355(9197):30-3. doi: 10.1016/S0140-6736(99)03366-8.
9
Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S434-41. doi: 10.1093/cid/civ551.
10
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.
引用本文的文献
1
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.
Vaccine X. 2024 Feb 23;18:100464. doi: 10.1016/j.jvacx.2024.100464. eCollection 2024 Jun.
2
Preventing invasive meningococcal disease in early infancy.
Hum Vaccin Immunother. 2022 Nov 30;18(5):1979846. doi: 10.1080/21645515.2021.1979846. Epub 2022 Apr 28.
3
Maternal vaccination: a review of current evidence and recommendations.
Am J Obstet Gynecol. 2022 Apr;226(4):459-474. doi: 10.1016/j.ajog.2021.10.041. Epub 2021 Nov 11.
4
Maternal immunisation to improve the health of HIV-exposed infants.
Lancet Infect Dis. 2019 Apr;19(4):e120-e131. doi: 10.1016/S1473-3099(18)30545-0. Epub 2018 Dec 7.
5
Mapping the landscape of global programmes to evaluate health interventions in pregnancy: the need for harmonised approaches, standards and tools.
BMJ Glob Health. 2018 Oct 15;3(5):e001053. doi: 10.1136/bmjgh-2018-001053. eCollection 2018.
6
Meningococcal vaccination in pregnancy.
Hum Vaccin Immunother. 2018 May 4;14(5):1188-1196. doi: 10.1080/21645515.2018.1445447. Epub 2018 Mar 21.
7
Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
Vaccine. 2017 Dec 4;35(48 Pt A):6563-6574. doi: 10.1016/j.vaccine.2017.01.047.
8
Group B vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.
F1000Res. 2016 Sep 22;5:2355. doi: 10.12688/f1000research.9363.1. eCollection 2016.
9
Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S501-6. doi: 10.1093/cid/civ509.
10
Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa.
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S389-90. doi: 10.1093/cid/civ592.
本文引用的文献
1
Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.
Vaccine. 2014 Dec 12;32(52):7057-64. doi: 10.1016/j.vaccine.2014.09.052. Epub 2014 Oct 5.
2
Profile of the Navrongo Health and Demographic Surveillance System.
Int J Epidemiol. 2012 Aug;41(4):968-76. doi: 10.1093/ije/dys111.
3
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).
Hum Vaccin Immunother. 2012 Jun;8(6):715-24. doi: 10.4161/hv.19619. Epub 2012 Apr 12.
4
Recent developments in Neisseria meningitidis group A conjugate vaccines.
Expert Opin Biol Ther. 2005 Feb;5(2):273-80. doi: 10.1517/14712598.5.2.273.
5
Maternal immunization against viral disease.
Vaccine. 1998 Aug-Sep;16(14-15):1456-63. doi: 10.1016/s0264-410x(98)00108-x.
Zotero 插件